NRP1 and pancreatic neoplasm: The study of Sema3A and its receptors, such as plexinsA1-A4 (PLXNA1-A4) and neuropilin-1 (NRP1) in PC, demonstrates that SEMA3A had no impact on the growth or survival of pancreatic tumor cells and was upregulated in PC.